Article · 2014
Editorial Board Member
Tadeusz Robak
Professor, Department of Hematology, Medical University of Lodz, Poland
About
As published by the journal they serve.
Dr. Tadeusz Robak is presently working as Professor of Hematology at the Medical University of Lodz and since 1997 he is Head of the Department of Hematology, at the Medical University and Copernicus Memorial Hospital in Lodz, Poland. He studied medicine at Medical University of Lodz and obtained his approval as hematologist in 1985 and clinical pharmacologist in 1987. In addition, he undertook further postgraduate training at Hammersmith Hospital and Royal Postgraduate Medical School in London. In 1996-2002 he was vice-rector and rector of the Medical University of Lodz. Professor Robak is a chairmen of the CLL subgroup of the Polish Adult Leukemia Study Group. He has written more than 500 journal articles 450 abstracts and 18 books or chapters. His special interests are on the application of nucleoside analogs and monoclonal antibodies in the treatment of leukemia and lymphoma. Professor Robak is involved in many translational research projects and was the principal investigator for several clinical trials of new drugs in leukemia, lymphoma and multiple myeloma. Prof. Tadeusz Robak has been selected by the World Scientists Forum for "Eminent Scientist of the year 2010" International Award in the field of Hematology-Oncology based on his research.
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Developing DrugsEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2012
New Kinase Inhibitors for the Treatment of Chronic Hematological Neoplasms-Editorial
Article · 2012
Developing Drugs for Leukemias
Article · 2020
Angiogenesis and Acute Respiratory Distress Syndrome for covid-19
Article · 2020
Editorial Note for Journal of Leukemia
Article · 2020
Journal of leukemia
Article · 2016
Editor Note
Article · 2016
Editor Note
Article · 2015
BCL-2 inhibitors for Chronic Lymphocytic Leukemia
Article · 2014
Staging and Prognostic Factors in Chronic Lymphocytic Leukemia: Current Status
Article · 2014
New Therapies for Hairy Cell Leukemia
Article · 2013
Inhibitors of B-Cell Receptor Signaling for the Treatment of Chronic Lymphocytic Leukemia
Article · 2011
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Article · 2009
Ofatumumab for the treatment of chronic lymphocytic leukemia
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
